163136-19-4 Usage
Uses
Used in Pharmaceutical Research:
Cannabisin F is used as a potential therapeutic agent for various health conditions due to its anti-cancer, neuroprotective, anti-viral, and anti-bacterial properties. It is being studied for its potential use in the development of new drugs, although further research is needed to fully understand its benefits and mechanisms of action.
Used in Anticancer Applications:
Cannabisin F is used as an anticancer agent, exhibiting potential therapeutic effects against various types of cancer. Its antioxidant and anti-inflammatory properties may contribute to its anti-cancer activity, although more research is required to determine its specific mechanisms of action and efficacy.
Used in Neuroprotective Applications:
Cannabisin F is used as a neuroprotective agent, potentially offering benefits for conditions involving neuronal damage or degeneration. Its antioxidant properties may help protect neurons from oxidative stress, a common factor in many neurodegenerative diseases.
Used in Antimicrobial Applications:
Cannabisin F is used as an antimicrobial agent, demonstrating potential anti-viral and anti-bacterial properties. Its ability to inhibit the growth of certain pathogens may make it a valuable compound in the development of new treatments for infectious diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 163136-19-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,1,3 and 6 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 163136-19:
(8*1)+(7*6)+(6*3)+(5*1)+(4*3)+(3*6)+(2*1)+(1*9)=114
114 % 10 = 4
So 163136-19-4 is a valid CAS Registry Number.
163136-19-4Relevant academic research and scientific papers
Total synthesis of cannabisin F
Xia, Ya-Mu,Xia, Jun,Chai, Chen
, p. 384 - 391 (2014/01/06)
A practical eight-step synthesis of lignanamide cannabisin F starting from vanillin is reported for the first time. This synthetic strategy applies the aldol reaction followed by the Wittig reaction to afford the key 8-O-4′-neolignan intermediate diacid. The diacid was condensed with N,O-protected tyramine giving, after deprotection, cannabisin F.
